Press release
Cunesoft GmbH and Jordan’s Drugstore Owners Association (DOA) Announce Strategic Partnership
Munich, Germany and Amman, Jordan — August 21, 2019 — Today, Cunesoft GmbH and DOA have announced their strategic partnership that will make eCTD submission software available to the members of DOA.“We are very excited to be able to work with DOA and bring Cunesoft’s cune-eCTD solution to DOA’s 19 corporate members,” said Rainer Schwarz, CEO at Cunesoft.
DOA’s members will now be able to easily license cune-eCTD in order to comply with Jordan’s eCTD submission requirement. “It was very important to us at DOA to partner with a leading provider of eCTD software that will be easy to use for our members,” said Thamer Obeidat, Secretary General of DOA. “Cunesoft’s software along with their positive industry reputation were key in developing this strategic partnership.”
Cunesoft’s cune-eCTD offers compliance with Jordan’s requirement for eCTD submissions while also including a seamlessly integrated document management capability.
About DOA:
The Drugstore Owners Association (DOA) was established in 1972 as a non-profit NGO to manage the relationship among the major pharmaceutical importers and distributors in Jordan as well as represent their professional and commercial interests with the public and private sector entities in the health care field.
DOA boasts the membership of 19 members whose operations account for a significant share of Jordan’s innovative pharmaceutical imports and who represent all the multinational R&D pharmaceutical manufacturers. For more information, visit www.doajo.net.
About Cunesoft:
Cunesoft GmbH is a provider of intelligent regulatory software and services for all segments within the life sciences industry. Solutions include management of eCTD, xEVMPD, IDMP data and document management as well as regulatory information management (RIM). Automated data mining based on NLP and Deep Learning algorithms complement the product portfolio. Software provisioning is provided as Private Software as a Service (SaaS). The company is headquartered in Munich (Germany) with international offices in the UK, US and India.
For more information, visit https://cunesoft.com/ .
Cunesoft GmbH
Luise-Ullrich-Strasse 20
80636 Munich, Germany
Neringa Antanaityte
About Cunesoft:
Cunesoft GmbH is a provider of intelligent regulatory software and services for all segments within the life sciences industry. Solutions include management of eCTD, xEVMPD, IDMP data and document management as well as regulatory information management (RIM). Automated data mining based on NLP and Deep Learning algorithms complement the product portfolio. Software provisioning is provided as Private Software as a Service (SaaS). The company is headquartered in Munich (Germany) with international offices in the UK, US and India.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cunesoft GmbH and Jordan’s Drugstore Owners Association (DOA) Announce Strategic Partnership here
News-ID: 1824828 • Views: …
More Releases for DOA
Europe Drug of Abuse (DOA) Testing Market Outlook and Opportunities in Grooming …
For many people in Europe, especially emotionally disturbed teens, drugs are their best friends! But, as everyone knows, whether an addict or not, drugs are not good. Though they help people escape their troubles for a while, they lead to long-lasting ill-effects, such as risk of AIDS and hepatitis C. Due to the increasing concerns among relatives and friends about drug abuse by their loved ones, they are rapidly using…
At-Home DOA Testing Market : Business Overview and Global Development Trends
Global At-Home DOA Testing Market: Overview
Developing unlawful medications use among young people, rising number of initiatives by the administration organizations to lessen the medication misuse levels, and expanded creation of engineered cannabinoids, bath salts, and other rising medications are boosting the interest for at-home DOA testing items in the market.
A report by Transparency Market Research (TMR) on the global at-home DOA testing market market is an adroit explanation…
DOA Testing Market Size, Leaders, Segment Analysis and Forecast Report 2023
The increasing adoption of drug of abuse (DOA) testing at the organizational level, growing number of road accidents and deaths, and rising consumption of illicit drugs are some of the reasons behind the growth of the DOA testing market. In 2016, the market generated a revenue of $4.8 billion, and it is predicted to advance at a CAGR of 9.6% during the forecast period (2017–2023). Drug testing refers to the…
Dioctyl Adipate (DOA) Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Dioctyl Adipate (DOA) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Dioctyl Adipate (DOA) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
At-Home Drug of Abuse (DOA) Testing Market Analysis with Research Report 2019
Global At-Home Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2019-2025
This report examines the existing as well as sequential performance of the worldwide market. The report also calculates the forthcoming status of At-Home Drug of Abuse (DOA) Testing market based on thorough analysis. By providing exploratory techniques such as, qualitative and quantitative analysis the report presents a comprehensive analysis of market progression. Graphical presentation of information through charts,…
Global Drug of Abuse (DOA) Testing Market to Witness 9.9% CAGR during 2018– 20 …
The driving factor for the growth of the global drug of abuse testing (DOA) testing market includes the advancement in technology for the development and production of DOA products with high specificity and sensitivity against complex new designer drugs. The reduction in testing time with newly developed products also drives the growth of the market.
To get a sample copy of this research report at https://www.vynzresearch.com/healthcare/drug-of-abuse-doa-testing-market/request-sample
Among different products, the rapid test…